期刊文献+

培哚普利对心肌梗死患者心肌重构的影响

Effects of perindopril on myocardial remodeling after myocardial infarction in patients
原文传递
导出
摘要 目的:探讨培哚普利对心肌梗死患者心肌重构的影响。方法:将100例心肌梗死患者随机分为治疗组和对照组各50例,2组患者均给予常规治疗,治疗组加用培垛普利(4mg.d-1),并于治疗前和治疗1年后比较二者左室短轴缩短率(FS)、左室重量指数(LMVI)、舒张早期与舒张晚期充盈速度比值(E/A),并对患者的心功能进行NYHA评级,观察药物的不良反应,统计因心衰入院率及死亡率。结果:1年后治疗组患者FS、LMVI、E/A、心功能、血压、心衰入院率和死亡率均好于对照组,差异有显著性(P<0.05)。结论:培哚普利阻抑左室重构过程,改善左室功能,效果更好,值得临床推广应用。 AKSTRACT:OBJECTIVE To explore the effects of perindopril on myocardial remodeling after myocardial infarction in patients. METHODS 100 cases with recent acute myocardial infarction (AMI) were randomly divided into the treatment group (50 cases) and the control group (50 cases) ;All patients received conventional therapy, the treatment group were plus treated with perindopril(4 mg. d^-1 1 ) for 12 months. The FS.LMVI.E/A and NYHA classification in all patients of two groups were observed and compared, the ad- verse effects, heart failure hospitalization rate and mortality were observed in all patients. RESULTS At t-year after treatments, the FS, LMVI, E/A, NYHA classification, heart failure hospitalization rate and mortality in treatment group were better than that in control group, there were significant difference(P〈0. 05). Cl)NCLUSION Perindopril can prohibit progressive left ventricular remode-ling, improve the left ventricular function after myocardial infarction in patient, so perindopril is worthy of being recommended in clinical practice.
作者 许立恒 却岚
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第11期924-926,共3页 Chinese Journal of Hospital Pharmacy
关键词 培哚普利 心肌梗死 心肌重构 perindopril myocardial infarction myocardial remodeling
  • 相关文献

参考文献8

  • 1Ferrari R, Chiariello M, Nicolosi GL, et al. Effects of angio tensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized perindopril and remodeling in elderly with acute myo cardial infarction study [J]. Arch Intern Med, 2006, 166(3) : 659-666.
  • 2Bolterman RJ, Manriquez MC, Ruiz MCO, et al. Effects of captopril on the renin angiotensin system, oxidative Stress, and endothelin in normal and hypertensive rats[J]. Hypertension, 2005,46: 943-947.
  • 3李传保,卜培莉.非诺贝特与高血压心肌重构[J].中国老年学杂志,2008,28(1):100-102. 被引量:3
  • 4祝善俊.心肌梗死后心肌重构防治进展[J].岭南心血管病杂志,2001,7(5):321-323. 被引量:3
  • 5Solomon SD, Skali H, Anavekar NS, et al. Changes in yen tricular size and function in patients treated with valsartan captopril, or both after myocardial infarction [J]. Circulation 2005, 111: 3411-3419.
  • 6Kaur K, Sharma AK, Singal PK. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2006, 291: 106-113.
  • 7王瑛,于凤秀.培哚普利、缬沙坦、螺内酯联合治疗慢性充血性心力衰竭的疗效观察[J].中国社区医师(医学专业),2008,10(19):21-21. 被引量:2
  • 8管小菊,白春林.培哚普利对原发性高血压左室舒张功能的影响[J].临床医药实践,2008,17(7):511-512. 被引量:1

二级参考文献27

  • 1Issemann I and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [J]. Nature, 1990 :347 : 645 -50.
  • 2Takehiro O,Takashi M,Satoshi S,et al. Stimulation of Peroxisome prolif- erator-activated receptors αattenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts [J]. Clinical Science,2002; 103:284s-8.
  • 3Takehiro O,Takashi M,Satoshi S,et al. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is amelio- rated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate ,partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway [ J ]. J Am Coll Cardiol, 2004 ; 43 : 1481-8.
  • 4Diez C, Nestler M, Friedrich U, et al. Down regulation of Akt/PKB in senescent cardic fibroblasts impairs PDGF-induced cell proliferation[J]. Cardiovase Res,2001 ;49:731-40.
  • 5Khan R, Sheppard R. Fibrosis in heart disease:understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and archythmia[ J ]. Immunology ,2006 ; 118 : 10-24.
  • 6Kuwahara F, Kai H, Tokuda K,et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats [J]. Circulation,2002 ; 106 : 130-5.
  • 7Seeland U, Haeuseler C, Hinrichs R,et al. Myocardial fibrosis in transforming growth factor beta ( 1 ) ( TGF-β1 ) transgenic mice is associated with inhibition of interstitial collagenase[J]. Eur J Clin Invest,2002 ;32 : 295-303.
  • 8Taniyama Y, Morshita R, Nakagami H, et at. Potential contribution of a novel antitibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin Ⅱ blockade in cardiomyopathic hamsters [J]. Circulation ,2000; 102:246-52.
  • 9Yunzeng Z,Issei K,Tsutomu Y,et al. Cell type-specific angiotensin Ⅱ evoked signal transduction pathways[J].Circ Res, 1998 ; 82:337.
  • 10BriUa CG. Aldosterone and myocardial fibrosis in heart failure[J]. Herz,2000 ;25:299-306.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部